Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27
Webcast Available Through Gilead Corporate Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L. Washington, Gilead’s Executive Vice President and Chief
Financial Officer, and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer and Head of Research & Development, will
participate in a fireside chat at the Evercore ISI HealthCONx Conference in Boston on Tuesday, November 27 at 9:30 a.m. Eastern
Time.
The audio portion of the fireside chat will be accessible live through the company’s Investors page at
www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to
ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14
days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please visit the company’s website at
www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or
1-650-574-3000.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Investor Relations
View source version on businesswire.com: https://www.businesswire.com/news/home/20181112005782/en/